Meet with our product experts in one-on-one virtual sessions and get a deep insight into our API Pharma Products offerings.

Our experts will answer your questions, provide advice, and help you understand our product better.

Set up a meeting

Verified

About Us:

Dr. Reddy’s Laboratories Ltd. is an integrated pharmaceutical company committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services & Active Ingredients, Global Generics, and Proprietary Products – Dr. Reddy’s is an active pharmaceutical ingredient supplier for foremost formulators and offers a portfolio of products and services, including APIs, custom pharmaceutical services, generics, biosimilars, and differentiated formulations.

As an active pharmaceutical ingredient manufacturer, our major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management, and dermatology. Dr. Reddy’s operates in markets across the globe. Our major markets include – USA, Europe, India, Russia, and other CIS countries.

Dr. Reddy's recognized at the CPhI Pharma Awards 2020 as the winner in the category of 'Excellence in Pharma: Sustainability'

At CPHI 2020 - We are honoured that our sustainability initiative has been recognized with the CPhI Pharma Award 2020 in the category of ‘Excellence..

At CPHI 2021 - Dr. Reddy's have been shortlisted for Excellence in Pharma

At CPHI 2021 - Dr. Reddys have been shortlisted for Excellence in Pharma: Regulatory Procedures and Compliance

The Portfolio of Dr. Reddy’s API Offerings

The Portfolio of Dr. Reddy’s API Offerings

Our Team

Disclaimer

No information in this catalog - including any reference to any product or service - constitutes an offer for sale, or be construed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, the research quantities of such products may be offered for the purpose of regulatory submissions, wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities. Products protected under valid patents in India are not available for commercial use but would be available for Section 107A purposes.